查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571910

病患登记软体的全球市场

Patient Registry Software
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球病患登记软体市场预计将达到 38 亿美元

全球病患登记软体市场预计 2023 年为 17 亿美元，预计到 2030 年将达到 38 亿美元，2023 年至 2030 年复合年增长率为 11.7%。产品註册是本报告分析的细分市场之一，预计复合年增长率为 11.0%，到分析期结束时将达到 9.929 亿美元。在分析期间，卫生服务註册部门的复合年增长率预计为 11.2%。

美国市场预计将成长4.661亿美元，中国复合年增长率为10.9%

预计 2023 年美国病患登记软体市场规模将达 4.661 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达到5.756亿美元，2023-2030年分析期间复合年增长率为10.9%。其他值得注意的地理市场包括日本和加拿大，在分析期间预计复合年增长率分别为 10.3% 和 9.9%。在欧洲，德国的复合年增长率预计约为 8.5%。

全球患者登记软体市场－主要趋势与驱动因素总结

科技将如何彻底改变病患登记软体市场？

随着技术进步使医疗保健组织能够更有效地收集、分析和利用大量患者资料，患者註册软体市场正在经历重大变革时期。传统上，病患登记是手动或纸本系统，在资料准确性、可近性和扩充性方面面临挑战。如今，云端基础的患者註册软体解决方案正在彻底改变患者资料的管理方式，使医疗保健提供者能够即时存取综合资料库。这些系统能够收集有关人口统计、治疗、结果甚至遗传资讯的结构化资料，以帮助医疗保健提供者做出明智的决策，以改善患者的治疗结果现在您可以。此外，将人工智慧（AI）和机器学习（ML）演算法整合到这些软体解决方案中将增强预测分析能力，从而实现疾病的早期检测、治疗效果分析以及患者的个人化护理策略。这些技术转变不仅简化了医院和研究机构的业务，也推动了公共卫生监测和临床研究的进步。

为什么医疗机构应采用病患登记软体

采用患者註册软体对于医疗保健组织来说变得越来越重要，以提高其追踪患者结果、监控治疗效果和遵守监管要求的能力。医院、研究机构和专科诊所依靠註册软体来管理慢性疾病患者、追踪临床试验参与者并收集资料用于人群健康管理。这些系统允许医疗保健提供者建立癌症、糖尿病或心血管疾病等特定疾病的登记处，透过详细的追踪和分析确保优化患者照护。此外，病患註册软体可确保病患资讯的安全、合规存储，从而使医疗保健组织能够遵守各种法规，例如美国的 HIPAA 和欧洲的 GDPR。与监管机构和研究机构共用註册资料的能力进一步增强了该系统在促进整个医疗保健生态系统协作方面的作用。患者登记软体还透过简化资料收集和报告来帮助改善临床决策和为患者提供的整体护理品质。

消费者和产业趋势如何影响患者註册软体市场？

对个人化医疗的需求不断增长以及以患者为中心的护理模式的兴起是影响患者註册软体市场成长的关键因素。随着医疗保健从一刀切的方法转向更个人化的护理模式，对全面的患者资料的需求变得至关重要。现今的患者更参与自己的护理，并期望根据他们的特定健康史、遗传背景和生活方式製定量身定制的治疗计划。病患登记软体在这一转变中发挥关键作用，它提供详细的纵向资料，使医生能够做出更准确的诊断和治疗决策。此外，穿戴式装置和行动医疗应用程式的兴起正在扩大患者资料的来源，为登记系统提供数据，并在传统临床环境之外提供对患者健康状况的即时洞察。这一趋势进一步突破了註册软体使用方式的界限，实现了对慢性病管理的持续监控，并促进了更积极主动的医疗保健服务。随着消费者对个人化医疗的期望不断提高，对支持这种不断发展的护理模式的註册解决方案的需求也在增加。

推动患者註册软体市场成长的因素有哪些？

患者登记软体市场的成长是由几个因素推动的，这些因素从根本上重塑了医疗保健资料的管理和利用。关键因素之一是慢性病的增加以及对长期患者追踪的相关需求，这正在推动医疗保健组织采用先进的註册软体解决方案。此外，临床研究活动的增加，特别是在肿瘤学、心臟病学和罕见疾病等领域，正在推动对强大的註册系统的需求，以支持随着时间的推移收集和分析患者资料。云端运算和人工智慧整合等技术进步正在实现可扩展且安全的解决方案，促进设施之间的即时资料共用和协作，进一步推动市场渗透。对资料透明度和遵守 GDPR 和 HIPAA 等全球医疗保健标准的监管要求也促使医疗保健组织投资于可靠的註册软体，以确保资料的安全性和完整性。此外，向注重改善患者治疗效果同时降低成本的基于价值的护理模式的转变增加了对资料主导的见解的需求，而患者註册软体正在帮助优化医疗服务，它被定位为促进精准医疗的重要工具。

受访企业举例（共42家）

  • Dacima Software, Inc.
  • Evado Pty. Ltd.
  • FIGmd, Inc.
  • Global Vision Technologies, Inc.
  • Ifa Systems AG
  • Imagetrend, Inc.
  • Liaison Technologies
  • M2S, Inc.
  • McKesson Corporation
  • Optum, Inc.
  • Velos, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP13881

Global Patient Registry Software Market to Reach US$3.8 Billion by 2030

The global market for Patient Registry Software estimated at US$1.7 Billion in the year 2023, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 11.7% over the analysis period 2023-2030. Product Registries, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$992.9 Million by the end of the analysis period. Growth in the Health Service Registries segment is estimated at 11.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$466.1 Million While China is Forecast to Grow at 10.9% CAGR

The Patient Registry Software market in the U.S. is estimated at US$466.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$575.6 Million by the year 2030 trailing a CAGR of 10.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.3% and 9.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.5% CAGR.

Global Patient Registry Software Market – Key Trends & Drivers Summarized

How Is Technology Revolutionizing the Patient Registry Software Market?

The patient registry software market is undergoing a significant transformation due to advances in technology, which are enabling healthcare organizations to collect, analyze, and utilize vast amounts of patient data more efficiently. Traditionally, patient registries were manual or paper-based systems, which posed challenges in data accuracy, accessibility, and scalability. Today, cloud-based patient registry software solutions have revolutionized how patient data is managed, offering healthcare providers real-time access to comprehensive databases. These systems enable the collection of structured data on demographics, treatments, outcomes, and even genetic information, empowering healthcare providers to make informed decisions that improve patient outcomes. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) algorithms within these software solutions is enhancing predictive analytics capabilities, allowing for early detection of diseases, treatment efficacy analysis, and personalized patient care strategies. This technological shift is not only streamlining operations in hospitals and research institutions but also driving advancements in public health surveillance and clinical research.

Why Are Healthcare Providers Embracing Patient Registry Software?

The adoption of patient registry software is becoming increasingly critical for healthcare providers, as it enhances the ability to track patient outcomes, monitor treatment effectiveness, and comply with regulatory requirements. Hospitals, research organizations, and specialty clinics are leveraging registry software to manage chronic disease populations, track clinical trial participants, and collect data for population health management. These systems enable healthcare providers to build disease-specific registries, such as for cancer, diabetes, or cardiovascular diseases, ensuring that patient care is optimized through detailed tracking and analytics. Moreover, the use of patient registry software helps healthcare organizations comply with various regulations such as HIPAA in the United States and GDPR in Europe, by ensuring the secure and compliant storage of patient information. The ability to share registry data with regulatory bodies and research organizations is further enhancing the role of these systems in fostering collaboration across the healthcare ecosystem. By streamlining data collection and reporting, patient registry software is also contributing to improved clinical decision-making and the overall quality of care provided to patients.

How Are Consumer and Industry Trends Influencing the Patient Registry Software Market?

The increasing demand for personalized medicine and the rise in patient-centric care models are significant factors influencing the growth of the patient registry software market. As healthcare shifts from a one-size-fits-all approach to a more individualized care model, the need for comprehensive patient data has become paramount. Patients today are more involved in their own care, expecting tailored treatment plans based on their specific health history, genetic background, and lifestyle. Patient registry software plays a crucial role in this shift by providing detailed longitudinal data that enables physicians to make more precise diagnoses and treatment decisions. In addition, the rise of wearable devices and mobile health applications is expanding the sources of patient data, feeding into registry systems and providing real-time insights into patient health outside of traditional clinical settings. This trend is further pushing the boundaries of how registry software is used, enabling continuous monitoring of chronic disease management and fostering a more proactive approach to healthcare delivery. As consumer expectations for personalized care grow, so too does the demand for registry solutions that support these evolving healthcare models.

What Factors Are Driving Growth in the Patient Registry Software Market?

The growth in the patient registry software market is driven by several factors that are fundamentally reshaping healthcare data management and utilization. One of the primary drivers is the increasing prevalence of chronic diseases and the subsequent need for long-term patient tracking, which is pushing healthcare organizations to adopt sophisticated registry software solutions. Additionally, the rise in clinical research activities, particularly in fields like oncology, cardiology, and rare diseases, is fueling demand for robust registry systems that can support patient data collection and analysis over extended periods. Technological advancements, such as the integration of cloud computing and AI, are enabling scalable and secure solutions that facilitate real-time data sharing and collaboration across institutions, further driving market adoption. Regulatory requirements for data transparency and compliance with global health standards, such as the GDPR and HIPAA, are also compelling healthcare providers to invest in reliable registry software that ensures data security and integrity. Furthermore, the shift towards value-based care models, which focus on improving patient outcomes while reducing costs, is creating a growing need for data-driven insights, positioning patient registry software as an essential tool in optimizing healthcare delivery and advancing precision medicine.

Select Competitors (Total 42 Featured) -

  • Dacima Software, Inc.
  • Evado Pty. Ltd.
  • FIGmd, Inc.
  • Global Vision Technologies, Inc.
  • Ifa Systems AG
  • Imagetrend, Inc.
  • Liaison Technologies
  • M2S, Inc.
  • McKesson Corporation
  • Optum, Inc.
  • Velos, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Patient Registry Software - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Emphasis on Data-Driven Healthcare Drives Growth of Patient Registry Software Solutions
    • Rising Adoption of EHR and Data Integration Solutions Expands Market for Interoperable Patient Registry Software
    • Growing Focus on Population Health Management Propels Demand for Comprehensive Patient Registry Solutions
    • Advancements in AI and Machine Learning Strengthen Predictive Analytics Capabilities in Patient Registry Software
    • Increased Demand for Real-World Evidence (RWE) in Clinical Research Expands Opportunities for Patient Registry Software in Drug Development
    • Rising Regulatory Requirements for Patient Data Collection and Reporting Drives Adoption of Registry Solutions for Compliance
    • Growing Focus on Chronic Disease Management Expands Market for Condition-Specific Patient Registry Systems
    • Emergence of Cloud-Based and SaaS Models Strengthens the Scalability of Patient Registry Software Solutions
    • Technological Advancements in Big Data Analytics Enhance the Role of Patient Registries in Personalized Medicine
    • Increased Use of Patient Registry Software for Longitudinal Studies in Healthcare Drives Demand in Clinical Trials
    • Rising Importance of Patient-Centric Care Models Expands the Market for Software Solutions that Support Multi-Stakeholder Data Access
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Patient Registry Software Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Patient Registry Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Patient Registry Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Patient Registry Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Product Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Product Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Product Registries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Health Service Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Health Service Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Health Service Registries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Disease Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Disease Registries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Disease Registries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals & Medical Practices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals & Medical Practices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals & Medical Practices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharma, Biotech & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pharma, Biotech & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Pharma, Biotech & Medical Device Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Government Organizations & TPAs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Government Organizations & TPAs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Government Organizations & TPAs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Patient Registry Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Patient Registry Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Patient Registry Software by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Patient Registry Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Patient Registry Software by Registry Type - Product Registries, Health Service Registries and Disease Registries Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Patient Registry Software by Registry Type - Percentage Breakdown of Value Sales for Product Registries, Health Service Registries and Disease Registries for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Patient Registry Software by End-Use - Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of World 16-Year Perspective for Patient Registry Software by End-Use - Percentage Breakdown of Value Sales for Hospitals & Medical Practices, Research Centers, Pharma, Biotech & Medical Device Companies, Government Organizations & TPAs and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION